Epiminder Appoints Mark McLellan as Chief Financial Officer

Epiminder, an Australian medical device company specializing in epilepsy monitoring technology, has appointed Mark McLellan as Chief Financial Officer as of October 21, 2025124.

Mark McLellan brings significant experience in healthcare finance, having previously worked at Beamtree Holdings Ltd and held roles in information technology, strategic planning, and financial advisory at rhipe (now Crayon), PwC, Ernst & Young, and the Royal Bank of Scotland124.

The appointment comes as Epiminder scales up commercial operations following recent FDA authorization of its Minder® implantable continuous EEG monitoring (iCEM®) system, aimed at improving epilepsy care in the US and globally124.

McLellan's expertise includes commercializing medical data services, supporting high growth technology businesses, and extensive advisory experience in IPOs, capital raising, acquisitions, and divestments124.

Epiminder’s Minder device allows for minimally invasive, long-term EEG monitoring, providing critical data to epilepsy patients and clinicians for better disease management12.

The company was founded in 2017, is headquartered in Melbourne, Australia, and has additional offices in the United States12.

Sources:

1. https://www.businesswire.com/news/home/20251021016518/en/Epiminder-Announces-Appointment-of-Mark-McLellan-as-Chief-Financial-Officer

2. https://www.morningstar.com/news/business-wire/20251021016518/epiminder-announces-appointment-of-mark-mclellan-as-chief-financial-officer

4. https://newshub.medianet.com.au/2025/10/epiminder-announces-appointment-of-mark-mclellan-as-chief-financial-officer/124679/